Results 21 to 30 of about 65,257 (310)
Guillain-Barre Syndrome Following Ad26.Cov2.S Covid-19 Vaccine: A Case Report
Journal of Nobel Medical College, 2021 Guillain-Barre Syndrome has been reported as a rare side effect in the recipients of Johnson & Johnson®'s Janssen Ad26.COV2.S COVID-19 vaccine. We report a case of Guillain-Barre Syndrome in a 50 years old female following the administration of the ...
Sushmita Khanal, Sunil Babu Khanal
doaj +1 more source
Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States
JAMA Network Open, 2023 This cohort study investigates the association of Ad26.COV2.S, BNT162b2, and mRNA-1273 COVID-19 vaccination with rates of Guillain-Barré syndrome among US adults.
W. Abara +12 more
semanticscholar +1 more source
Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine
Cureus, 2021 Since the first case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in Wuhan, China, in December 2019, Coronavirus - 19 (COVID-19) has become a global pandemic with multiple neurological complications.
S. Waheed +4 more
semanticscholar +1 more source
Guillain–Barre syndrome after myocardial infarction: a case report and literature review
BMC Cardiovascular Disorders, 2023 Background Guillain–Barre syndrome after myocardial infarction occurs infrequently, and its occurrence following percutaneous coronary intervention is extremely rare.
Pu-yuan Wen +5 more
doaj +1 more source
Guillain–Barré Syndrome Associated with SARS-CoV-2
New England Journal of Medicine, 2020 Guillain–Barre Syndrome with Covid-19 Five patients who had Guillain–Barre syndrome 5 to 10 days after the onset of Covid-19 are described.
G. Toscano +11 more
semanticscholar +1 more source
European Journal of Neurology, 2021 Mounting evidence supports an association between Guillain−Barré syndrome spectrum (GBSs) and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection.
L. Palaiodimou +13 more
semanticscholar +1 more source
Нервно-мышечные болезни, 2020 Introduction. The heterogeneity of the forms and severity of Guillain-Barre syndrome explains the variability of recovery: from rapid and complete (in most cases) to slow with the development of persistent residual deficiency (rarely).
D. A. Grishina, N. A. Suponeva
doaj +1 more source
Journal of Neurology, 2020 Since coronavirus disease-2019 (COVID-19) outbreak in January 2020, several pieces of evidence suggested an association between the spectrum of Guillain–Barré syndrome (GBS) and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Samir Abu-Rumeileh +4 more
semanticscholar +1 more source
BMJ Case Reports, 2021 Prevention strategies for COVID-19 transmission are at the forefront of healthcare paradigms worldwide, the main emphasis of which is vaccination. We present an interesting case of a 37-year-old man who, 3 weeks following his first dose of the chimpanzee
Shreena Patel +3 more
semanticscholar +1 more source
Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome
medRxiv, 2020 Background Reports of Guillain-Barre Syndrome (GBS) have emerged during the Coronavirus Disease 2019 (COVID-19) pandemic. This epidemiological and cohort study sought to investigate any causative association between COVID-19 infection and GBS.
S. Keddie +41 more
semanticscholar +1 more source